# Zentalis Pharmaceuticals, Inc.: filings

ZNTL · Nasdaq · CIK 1725160 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/zntl.md) · [Financials](/companies/zntl/financials.md) · [Filings](/companies/zntl/filings.md) · [Insiders](/companies/zntl/insiders.md)

## Reports and events: 133 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 221, 8-K 89, SC 13G/A 29, 3 28, 144 22, 10-Q 20, SC 13G 17, DEFA14A 12, SCHEDULE 13G/A 12, CORRESP 10, UPLOAD 9, 424B5 7, 10-K 6, DEF 14A 6, S-8 5, ARS 4, SCHEDULE 13G 4, 4/A 3, EFFECT 3, S-1/A 3, 424B4 2, 8-K/A 2, D 2, DRS 2, S-1 2, S-3 2, S-3ASR 2, SCHEDULE 13D/A 2, SEC STAFF LETTER 2, 10-K/A 1, 8-A12B 1, CERT 1, DRS/A 1, DRSLTR 1, FWP 1, PRE 14A 1, RW 1, S-1MEF 1, SC 13D 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-14 | 16:09 ET | [8-K](/filings/0001628280-26-057112.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-057112 |
| 2026-08-06 | 16:13 ET | [10-Q](/filings/0001725160-26-000062.md) | Quarterly report, period 2026-06-30 | 0001725160-26-000062 |
| 2026-08-06 | 16:10 ET | [8-K](/filings/0001725160-26-000061.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001725160-26-000061 |
| 2026-06-18 | 16:03 ET | [8-K](/filings/0001725160-26-000052.md) | 5.07 Shareholder vote results | 0001725160-26-000052 |
| 2026-05-27 | 16:07 ET | [8-K](/filings/0001725160-26-000049.md) | 5.02 Departure or appointment of officers or directors | 0001725160-26-000049 |
| 2026-05-21 | 17:29 ET | [8-K](/filings/0001725160-26-000045.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001725160-26-000045 |
| 2026-05-12 | 16:11 ET | [10-Q](/filings/0001725160-26-000042.md) | Quarterly report, period 2026-03-31 | 0001725160-26-000042 |
| 2026-05-12 | 16:10 ET | [8-K](/filings/0001725160-26-000041.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001725160-26-000041 |
| 2026-05-05 | 08:01 ET | [8-K](/filings/0001725160-26-000033.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001725160-26-000033 |
| 2026-04-30 | 16:06 ET | [DEF 14A](/filings/0001725160-26-000027.md) | Proxy statement, period 2026-06-16 | 0001725160-26-000027 |
| 2026-04-17 | 15:11 ET | [8-K](/filings/0001725160-26-000020.md) | 7.01 Regulation FD disclosure | 0001725160-26-000020 |
| 2026-04-09 | 08:01 ET | [8-K](/filings/0001725160-26-000017.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001725160-26-000017 |
| 2026-03-26 | 16:46 ET | [10-K](/filings/0001725160-26-000014.md) | Annual report, period 2025-12-31 | 0001725160-26-000014 |
| 2026-03-26 | 16:24 ET | [8-K](/filings/0001725160-26-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001725160-26-000010 |
| 2026-01-09 | 17:18 ET | [8-K](/filings/0001725160-26-000003.md) | 7.01 Regulation FD disclosure; 8.01 Other events | 0001725160-26-000003 |
| 2026-01-02 | 16:10 ET | [SCHEDULE 13D/A](/filings/0000902664-26-000024.md) | Ownership report, active investor, amended | 0000902664-26-000024 |
| 2025-12-15 | 17:16 ET | [SCHEDULE 13D/A](/filings/0000902664-25-005287.md) | Ownership report, active investor, amended | 0000902664-25-005287 |
| 2025-12-15 | 17:01 ET | [8-K](/filings/0001725160-25-000164.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001725160-25-000164 |
| 2025-11-10 | 16:15 ET | [10-Q](/filings/0001725160-25-000161.md) | Quarterly report, period 2025-09-30 | 0001725160-25-000161 |
| 2025-11-10 | 16:11 ET | [8-K](/filings/0001725160-25-000159.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001725160-25-000159 |
| 2025-08-26 | 16:08 ET | [8-K](/filings/0001725160-25-000154.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001725160-25-000154 |
| 2025-08-06 | 16:13 ET | [10-Q](/filings/0001725160-25-000149.md) | Quarterly report, period 2025-06-30 | 0001725160-25-000149 |
| 2025-08-06 | 16:08 ET | [8-K](/filings/0001725160-25-000147.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001725160-25-000147 |
| 2025-06-18 | 16:09 ET | [8-K](/filings/0001725160-25-000127.md) | 5.07 Shareholder vote results | 0001725160-25-000127 |
| 2025-06-02 | 06:02 ET | [8-K](/filings/0001725160-25-000119.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001725160-25-000119 |
| 2025-05-20 | 06:01 ET | [8-K](/filings/0001725160-25-000108.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001725160-25-000108 |
| 2025-05-14 | 16:13 ET | [10-Q](/filings/0001725160-25-000105.md) | Quarterly report, period 2025-03-31 | 0001725160-25-000105 |
| 2025-05-14 | 16:09 ET | [8-K](/filings/0001725160-25-000104.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001725160-25-000104 |
| 2025-04-30 | 16:09 ET | [DEF 14A](/filings/0001725160-25-000092.md) | Proxy statement, period 2025-06-17 | 0001725160-25-000092 |
| 2025-04-28 | 06:02 ET | [8-K](/filings/0001725160-25-000082.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001725160-25-000082 |
| 2025-03-26 | 16:19 ET | [8-K](/filings/0001725160-25-000070.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001725160-25-000070 |
| 2025-03-26 | 16:11 ET | [10-K](/filings/0001725160-25-000067.md) | Annual report, period 2024-12-31 | 0001725160-25-000067 |
| 2025-03-17 | 06:13 ET | [8-K](/filings/0001628280-25-012899.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-012899 |
| 2025-01-29 | 09:18 ET | [8-K](/filings/0001725160-25-000013.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001725160-25-000013 |
| 2025-01-28 | 16:07 ET | [8-K](/filings/0001725160-25-000006.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001725160-25-000006 |
| 2024-12-19 | 16:01 ET | [8-K/A](/filings/0001725160-24-000193.md) | 5.02 Departure or appointment of officers or directors | 0001725160-24-000193 |
| 2024-11-13 | 08:06 ET | [8-K](/filings/0001725160-24-000177.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001725160-24-000177 |
| 2024-11-12 | 16:00 ET | [10-Q](/filings/0001725160-24-000173.md) | Quarterly report, period 2024-09-30 | 0001725160-24-000173 |
| 2024-09-16 | 07:02 ET | [8-K](/filings/0001725160-24-000161.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001725160-24-000161 |
| 2024-08-09 | 07:03 ET | [10-Q](/filings/0001725160-24-000158.md) | Quarterly report, period 2024-06-30 | 0001725160-24-000158 |
| 2024-08-09 | 07:01 ET | [8-K](/filings/0001725160-24-000157.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001725160-24-000157 |
| 2024-06-21 | 17:06 ET | [8-K](/filings/0001725160-24-000140.md) | 5.07 Shareholder vote results | 0001725160-24-000140 |
| 2024-06-03 | 07:00 ET | [8-K](/filings/0001725160-24-000131.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001725160-24-000131 |
| 2024-05-29 | 07:04 ET | [8-K](/filings/0001725160-24-000120.md) | 5.02 Departure or appointment of officers or directors | 0001725160-24-000120 |
| 2024-05-07 | 07:05 ET | [10-Q](/filings/0001725160-24-000107.md) | Quarterly report, period 2024-03-31 | 0001725160-24-000107 |
| 2024-05-07 | 07:03 ET | [8-K](/filings/0001725160-24-000106.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001725160-24-000106 |
| 2024-04-29 | 16:34 ET | [DEF 14A](/filings/0001725160-24-000096.md) | Proxy statement, period 2024-06-21 | 0001725160-24-000096 |
| 2024-04-11 | 07:00 ET | [8-K](/filings/0001725160-24-000087.md) | 5.02 Departure or appointment of officers or directors | 0001725160-24-000087 |
| 2024-04-09 | 16:30 ET | [8-K](/filings/0001725160-24-000082.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001725160-24-000082 |
| 2024-02-27 | 07:08 ET | [10-K](/filings/0001725160-24-000080.md) | Annual report, period 2023-12-31 | 0001725160-24-000080 |

Page 1 of 3. [Older](/companies/zntl/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:29 ET. No prices; not investment advice.